z-logo
open-access-imgOpen Access
The efficacy of T790M mutation testing in liquid biopsy—Real clinic data
Author(s) -
Paweł Krawczyk,
Luiza GrzyckaKowalczyk,
Justyna Błach,
Katarzyna Reszka,
Izabela Chmielewska,
Robert Kieszko,
Magdalena Wójcik-Superczyńska,
Michał Szczyrek,
Tomasz Jankowski,
Janusz Milanowski
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0267846
Subject(s) - t790m , medicine , gefitinib , afatinib , liquid biopsy , mutation , erlotinib , resistance mutation , adenocarcinoma , oncology , biopsy , gene mutation , pathology , cancer , gastroenterology , epidermal growth factor receptor , polymerase chain reaction , biology , gene , genetics , reverse transcriptase

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom